[h5p id=”129″]Recommend0 recommendationsPublished in
The White House’s budget request to Congress included an $11 billion ask to tackle the spread of the hepatitis C virus (HCV) over the next five years. Though it’s not a crisis that’s well-known or understood, public health efforts in the last 10 years have made strides toward prevention and treatment. Direct-acting antivirals developed […]
The post Here You Can Read About A New Focus on Hepatitis appeared first on Pennsylvania Office of Rural Health.
Researchers at The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio are recruiting participants for the VIVA-MIND study to learn whether a new drug therapy for Alzheimer’s disease can help people experiencing mild memory problems. Volunteers ages 50 to 89 with a diagnosis of mild cognitive impairment or probable mild …
The post Join the VIVA-MIND Study of an Oral Drug for Alzheimer’s! appeared first on Salud America.